Selective targeting of nanocarriers to neutrophils and monocytes

Annals of Biomedical Engineering

Volumn 37, Issue 10, 2009, Pages 1984-1992

  Karathanasis, Efstathios ^a   Geigerman, Cissy M ^b   Parkos, Charles A ^b   Chan, Leslie ^a   Bellamkonda, Ravi V ^a   Jaye, David L ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Leukocytes; Liposomes; Nanotechnology; Phage display; Targeting

Indexed keywords

BINDING SELECTIVITY; CELL UPTAKE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; COAGULATED BLOOD; FLOW-CYTOMETRIC ANALYSIS; FLUORESCENCE CONFOCAL MICROSCOPY; HUMAN BLOOD CELLS; IMAGING AGENT; IN-CELL; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; LEUKOCYTES; LIPOSOMAL NANOCARRIERS; NANOCARRIERS; NON-TARGETED; NUCLEAR LOCALIZATION; PEPTIDE LIGAND; PHAGE DISPLAY; PHAGE DISPLAY LIBRARIES; SELECTIVE BINDING; TARGETING;

AMINES; BLOOD; CELL MEMBRANES; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; LIPOSOMES; NANOTECHNOLOGY; PATHOLOGY; PHOSPHOLIPIDS;

PEPTIDES;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER; LIPOSOME; NANOMATERIAL;

ARTICLE; CELL CULTURE; CHEMISTRY; HUMAN; METABOLISM; MONOCYTE; NEUTROPHIL; ULTRASTRUCTURE;

ANTIBIOTICS, ANTINEOPLASTIC; CELLS, CULTURED; DOXORUBICIN; DRUG CARRIERS; HUMANS; LIPOSOMES; MONOCYTES; NANOSTRUCTURES; NEUTROPHILS;

EID: 70349212253     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-009-9702-5     Document Type: Article

References (44)

1. E. Bolotin R. Cohen L. Bar N. Emanuel S. Ninio D. Lasic Y. Barenholz 1994 Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes J. Liposome Res. 4 455 479 10.3109/08982109409037057 10.3109/08982109409037057
2. A. M. Derfus A. A. Chen D. H. Min E. Ruoslahti S. N. Bhatia 2007 Targeted quantum dot conjugates for siRNA delivery Bioconjugate Chem. 18 5 1391 1396 10.1021/bc060367e 10.1021/bc060367e 1:CAS:528:DC%2BD2sXotVSnsbY%3D (Pubitemid 47464045)
3. O. C. Farokhzad S. Jon A. Khademhosseini T. N. Tran D. A. Lavan R. Langer 2004 Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Res. 64 21 7668 7672 10.1158/0008-5472.CAN-04-2550 15520166 10.1158/0008-5472.CAN-04-2550 1:CAS:528:DC%2BD2cXptFemtbs%3D (Pubitemid 39446893)
4. M. Ferrari 2005 Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 3 161 171 10.1038/nrc1566 15738981 10.1038/nrc1566 1:CAS:528:DC%2BD2MXhslSnt7o%3D (Pubitemid 40314948)
5. S. B. Hanauer 2006 Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities Inflamm. Bowel Dis. 12 Suppl 1 S3 9 10.1097/01.MIB.0000195385.19268.68 16378007 10.1097/01.MIB.0000195385.19268.68 (Pubitemid 43068428)
6. G. Hermanson, Bioconjugate Techniques, Academic Press, New York, 1996.
7. S. Hong P. R. Leroueil I. J. Majoros B. G. Orr J. R. Baker Jr. M. M. Banaszak Holl 2007 The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem. Biol. 14 1 107 115 10.1016/j.chembiol. 2006.11.015 17254956 10.1016/j.chembiol.2006.11.015 1:CAS:528: DC%2BD2sXhtVaqsLY%3D (Pubitemid 46124068)
8. R. K. Jain 1994 Barriers to drug delivery in solid tumors Sci. Am. 271 1 58 65 8066425 1:STN:280:DyaK2czksFenuw%3D%3D
9. R. K. Jain 1999 Transport of molecules, particles, and cells in solid tumors Annu. Rev. Biomed. Eng. 1 241 263 10.1146/annurev.bioeng.1.1.241 11701489 10.1146/annurev.bioeng.1.1.241 1:CAS:528:DyaK1MXnvFyit7c%3D
10. R. K. Jain 2001 Delivery of molecular and cellular medicine to solid tumors Adv. Drug Deliv. Rev. 46 1-3 149 168 10.1016/S0169-409X(00)00131-9 11259838 10.1016/S0169-409X(00)00131-9 1:CAS:528:DC%2BD3MXitVOhsLw%3D
11. B. Javaid R. J. Quigg 2005 Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics? Kidney Int. 67 5 1692 1703 10.1111/j.1523-1755.2005.00266.x 15840015 10.1111/j.1523-1755.2005.00266.x 1:CAS:528:DC%2BD2MXktlOqur4%3D (Pubitemid 40577703)
12. D. L. Jaye H. A. Edens L. Mazzucchelli C. A. Parkos 2001 Novel G protein-coupled responses in leukocytes elicited by a chemotactic bacteriophage displaying a cell type-selective binding peptide J Immunol 166 12 7250 7259 11390474 1:CAS:528:DC%2BD3MXksVOnuro%3D
13. D. L. Jaye C. M. Geigerman R. E. Fuller A. Akyildiz C. A. Parkos 2004 Direct fluorochrome labeling of phage display library clones for studying binding specificities: applications in flow cytometry and fluorescence microscopy J. Immunol. Methods 295 1-2 119 127 10.1016/j.jim.2004.09.011 15627617 10.1016/j.jim.2004.09.011 1:CAS:528:DC%2BD2MXotVeq (Pubitemid 41057774)
14. D. L. Jaye F. S. Nolte L. Mazzucchelli C. Geigerman A. Akyildiz C. A. Parkos 2003 Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display Am. J. Pathol. 162 5 1419 1429 12707025 1:CAS:528:DC%2BD3sXjsl2mtbc%3D
15. D. L. Jaye C. A. Parkos 2000 Neutrophil migration across intestinal epithelium Ann. NY Acad. Sci. 915 151 161 11193572 1:CAS:528: DC%2BD3MXntVCgug%3D%3D
16. E. Karathanasis L. Chan S. R. Balusu C. J. D'Orsi A. V. Annapragada I. Sechopoulos R. V. Bellamkonda 2008 Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy Biomaterials 29 36 4815 4822 10.1016/j.biomaterials.2008.08.036 18814908 10.1016/j.biomaterials.2008.08.036 1:CAS:528:DC%2BD1cXht1Grt7fN
17. Karathanasis, E., J. Park, A. Agarwal, V. Patel, F. Zhao, A. V. Annapragada, X. Hu, R. V. Bellamkonda. MRI mediated, non-invasive tracking of intratumoral distribution of nanocarriers in rat glioma. Nanotechnology 19:315101 (315109), 2008
18. E. Karathanasis S. Suryanarayanan S. R. Balusu K. McNeeley I. Sechopoulos A. Karellas A. V. Annapragada R. V. Bellamkonda 2009 Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography Radiology 250 2 398 406 10.1148/radiol.2502080801 19188313 10.1148/radiol. 2502080801
19. K. A. Kelly J. R. Allport A. Tsourkas V. R. Shinde-Patil L. Josephson R. Weissleder 2005 Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle Circulat. Res. 96 3 327 336 10.1161/01.RES. 0000155722.17881.dd 15653572 10.1161/01.RES.0000155722.17881.dd 1:CAS:528:DC%2BD2MXhtF2nsL0%3D (Pubitemid 40279907)
20. K. A. Kelly P. A. Clemons A. M. Yu R. Weissleder 2006 High-throughput identification of phage-derived imaging agents Mol. Imaging 5 1 24 30 16779967
21. K. A. Kelly M. Nahrendorf A. M. Yu F. Reynolds R. Weissleder 2006 In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging Mol. Imaging Biol. 8 4 201 207 10.1007/s11307-006-0043-6 16791746 10.1007/s11307-006-0043-6 (Pubitemid 44193415)
22. J. H. Kim J. S. Kim H. Choi S. M. Lee B. H. Jun K. N. Yu E. Kuk Y. K. Kim D. H. Jeong M. H. Cho Y. S. Lee 2006 Nanoparticle probes with surface enhanced Raman spectroscopic tags for cellular cancer targeting Anal. Chem. 78 19 6967 6973 10.1021/ac0607663 17007522 10.1021/ac0607663 1:CAS:528:DC%2BD28XotlCntbw%3D (Pubitemid 44522550)
23. A. R. Kitching S. R. Holdsworth M. J. Hickey 2008 Targeting leukocytes in immune glomerular diseases Curr. Med. Chem. 15 5 448 458 10.2174/ 092986708783503230 18289000 10.2174/092986708783503230 1:CAS:528: DC%2BD1cXnsVyisLg%3D
24. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control Release 65 1-2 271 284 10.1016/S0168-3659(99)00248-5 10699287 10.1016/S0168-3659(99)00248-5 1:CAS:528:DC%2BD3cXhtl2qsLo%3D (Pubitemid 30122932)
25. L. D. Mayer M. B. Bally M. J. Hope P. R. Cullis 1985 Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential Biochim. Biophys. Acta 816 2 294 302 10.1016/0005-2736(85)90497-3 3839135 10.1016/0005-2736(85)90497-3 1:CAS:528:DyaL2MXkslKitr8%3D (Pubitemid 15047328)
26. L. Mazzucchelli J. B. Burritt A. J. Jesaitis A. Nusrat T. W. Liang A. T. Gewirtz F. J. Schnell C. A. Parkos 1999 Cell-specific peptide binding by human neutrophils Blood 93 5 1738 1748 10029604 1:CAS:528:DyaK1MXhsFeqsrY%3D
27. J. R. McCarthy K. A. Kelly E. Y. Sun R. Weissleder 2007 Targeted delivery of multifunctional magnetic nanoparticles Nanomedicine (London, England) 2 2 153 167 1:CAS:528:DC%2BD2sXjsVCjtbc%3D
28. D. M. McDonald 2001 Angiogenesis and remodeling of airway vasculature in chronic inflammation Am. J. Respir. Crit. Care Med. 164 10 Pt 2 S39 45 11734465 1:STN:280:DC%2BD3Mnosl2qtQ%3D%3D
29. D. M. McDonald G. Thurston P. Baluk 1999 Endothelial gaps as sites for plasma leakage in inflammation Microcirculation 6 1 7 22 10.1080/713773924 10100186 10.1080/713773924 1:STN:280:DyaK1M7pvF2muw%3D%3D
30. M. J. McGuire K. F. Sykes K. N. Samli L. Timares M. A. Barry K. Stemke-Hale F. Tagliaferri M. Logan K. Jansa A. Takashima K. C. Brown S. A. Johnston 2004 A library-selected, Langerhans cell-targeting peptide enhances an immune response DNA Cell Biol. 23 11 742 752 10.1089/dna.2004.23.742 15585132 10.1089/dna.2004.23.742 1:CAS:528:DC%2BD2cXhtVWgtLfO
31. X. X. Meng J. Q. Wan M. Jing S. G. Zhao W. Cai E. Z. Liu 2007 Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents Acta Pharmacol. Sinica 28 12 2019 2026 10.1111/j.1745-7254.2007.00661.x 10.1111/j.1745-7254.2007.00661.x 1:CAS:528:DC%2BD2sXhsVGlsbnJ (Pubitemid 350198333)
32. J. A. Nagy L. Benjamin H. Zeng A. M. Dvorak H. F. Dvorak 2008 Vascular permeability, vascular hyperpermeability and angiogenesis Angiogenesis 11 2 109 119 10.1007/s10456-008-9099-z 18293091 10.1007/s10456-008-9099-z 1:CAS:528:DC%2BD1cXmvVCgu7w%3D
33. M. Nahrendorf F. A. Jaffer K. A. Kelly D. E. Sosnovik E. Aikawa P. Libby R. Weissleder 2006 Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis Circulation 114 14 1504 1511 10.1161/CIRCULATIONAHA.106.646380 17000904 10.1161/CIRCULATIONAHA. 106.646380 1:CAS:528:DC%2BD28XpvFGmtbc%3D (Pubitemid 44527006)
34. D. K. Pillai S. G. Matts 1983 Chronic inflammatory bowel disease-a review Br. J. Clin. Pract. 37 5 165 172 6349671 1:STN:280:DyaL3s3otlamtw%3D%3D
35. A. Pope-Harman M. M. Cheng F. Robertson J. Sakamoto M. Ferrari 2007 Biomedical nanotechnology for cancer Med. Clin. North Am. 91 5 899 927 10.1016/j.mcna.2007.05.008 17826110 10.1016/j.mcna.2007.05.008 1:CAS:528:DC%2BD2sXht1SrsrfF (Pubitemid 47361211)
36. J. M. Saul A. V. Annapragada R. V. Bellamkonda 2006 A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers J. Control Release 114 3 277 287 10.1016/j.jconrel.2006.05.028 16904220 10.1016/j.jconrel.2006.05.028 1:CAS:528:DC%2BD28Xpt1Omtb4%3D (Pubitemid 44310813)
37. R. F. Service 2005 Materials and biology. Nanotechnology takes aim at cancer Science 310 5751 1132 1134 10.1126/science.310.5751.1132 16293748 10.1126/science.310.5751.1132 (Pubitemid 41681730)
38. Sood, S. Characterization of liposome manufacturing using extrusion. Master's thesis, San Jose State University, 1999.
39. T. D. Tetley 2005 Inflammatory cells and chronic obstructive pulmonary disease Curr. Drug Targets Inflamm. Allergy 4 6 607 618 10.2174/ 156801005774912824 17305517 10.2174/156801005774912824 1:CAS:528: DC%2BD2MXht1GrtbjM (Pubitemid 41722371)
40. I. Tillie-Leblond P. Gosset A. B. Tonnel 2005 Inflammatory events in severe acute asthma Allergy 60 1 23 29 10.1111/j.1398-9995.2005.00632.x 15575926 10.1111/j.1398-9995.2005.00632.x 1:STN:280:DC%2BD2cngt1CqsQ%3D%3D
41. A. G. Tkachenko H. Xie D. Coleman W. Glomm J. Ryan M. F. Anderson S. Franzen D. L. Feldheim 2003 Multifunctional gold nanoparticle-peptide complexes for nuclear targeting J. Am. Chem. Soc. 125 16 4700 4701 10.1021/ja0296935 12696875 10.1021/ja0296935 1:CAS:528:DC%2BD3sXisVaks70%3D (Pubitemid 36505350)
42. R. Vlahos S. Bozinovski J. A. Hamilton G. P. Anderson 2006 Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF) Pharmacol. Ther. 112 1 106 115 10.1016/j.pharmthera.2006.03.007 16716406 10.1016/j.pharmthera.2006.03.007 1:CAS:528:DC%2BD28XptFCitr8%3D (Pubitemid 44301488)
43. J. Xie Z. Shen K. C. Li N. Danthi 2007 Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle Int. J. Nanomed. 2 3 479 485 1:CAS:528:DC%2BD2sXhtlektbjO
44. M. V. Yezhelyev X. Gao Y. Xing A. Al-Hajj S. Nie R. M. O'Regan 2006 Emerging use of nanoparticles in diagnosis and treatment of breast cancer Lancet Oncol. 7 8 657 667 10.1016/S1470-2045(06)70793-8 16887483 10.1016/S1470- 2045(06)70793-8 1:CAS:528:DC%2BD28Xns12ntbs%3D (Pubitemid 44143778)